San Diego Convention Center

The America's Most Exciting Biologics Event is a comprehensive gathering that focuses on the rapidly evolving field of biologics, bringing together industry leaders, researchers, and professionals involved in the discovery, development, and commercialization of biologic therapies. This event covers the entire biologics lifecycle, from early-stage discovery to clinical trials, manufacturing, and market access, providing critical insights into the future of biologic treatments.

Key Features:

1. Disease Area Focus: Explore how biologics are transforming treatments in key disease areas, including oncology, immunology, neurology, and infectious diseases. Leading experts discuss the latest breakthroughs and innovative therapies that are shaping the future of medicine.

2. Therapies and Modalities: Sessions cover a wide range of biologic therapies, such as:

   • Monoclonal antibodies
   • Cell and gene therapies
   • Protein-based therapies
   • Vaccines and RNA-based therapeutics These therapies represent the cutting edge of personalized and precision medicine.

3. Discovery & Development: Gain insights into the latest advancements in biologic drug discovery, including the identification of novel targets, the application of biotechnology, and biomarker research. Learn about innovative development strategies that accelerate the pipeline from preclinical research to clinical trials.

4. Clinical Trial Operations: The event features discussions on optimizing clinical trial design and operations, with a focus on biologics. Explore best practices for improving trial efficiency, regulatory compliance, and patient recruitment in biologic clinical trials.

5. Manufacturing & Supply Chain: Discover new approaches to biologics manufacturing, including scalable bioprocessing technologies, biopharma automation, and solutions for improving supply chain management in a highly regulated environment.

6. Finance & Investment: Experts from the investment community share insights on funding biotech innovation and the latest trends in biotech financing. Gain an understanding of how venture capital, private equity, and corporate partnerships are shaping the biologics landscape.

7. Commercialization & Market Access: Learn strategies for successfully bringing biologic therapies to market. Sessions focus on market access, pricing strategies, reimbursement, and health economics, helping companies navigate the challenges of launching and scaling biologic products in a competitive marketplace.

Why Attend?

• Learn from Industry Experts: Hear from top researchers, biotech companies, and regulatory authorities about the latest advancements and challenges in biologics.
• Discover New Technologies: Explore innovations in biologics discovery, development, and manufacturing that are changing the way therapies are developed and delivered.
• Network with Key Players: Connect with industry leaders, biotech executives, investors, and policymakers to build partnerships and collaborations.
• Stay Ahead of Trends: Understand the emerging trends in biotech investment, regulatory landscapes, and market dynamics that will influence the future of biologics.

Who Should Attend?

• Biotech and pharmaceutical executives involved in the development of biologic therapies
• Researchers and scientists focused on biologic drug discovery and development
• Clinical trial professionals seeking insights into biologic trial design and operations
• Regulatory experts and policymakers working in the biologics sector
• Investors and venture capitalists interested in funding biotech innovations
• Healthcare professionals and market access experts involved in the commercialization of biologic products

This event is a must-attend for anyone involved in the biologics industry, offering the latest knowledge, strategies, and connections to advance biologic therapies from bench to bedside